Products

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DCAPI1516	Eribulin	Eribulin Mesylate (E7389 Mesylate), a synthetic analogue of halichondrin B in phase III clinical trials for breast cancer, binds to tubulin and microtubules.
DC22441	Eritoran tetrasodium	Eritoran tetrasodium (E5564) is an investigational drug for the treatment of severe sepsis that acts as a TLR4 antagonist..
DC26018	ERK5-IN-2 Featured	ERK5-IN-2 is an orally active, sub-micromolar, selective ERK5 inhibitor with IC50s of 0.82 μM, 3 μM for ERK5 and ERK5 MEF2D, respectively.
DC22486	Erlotinib mesylate Featured	Erlotinib is an epidermal growth factor receptor inhibitor (EGFR inhibitor). Erlotinib HCl was approved. Erlotinib binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. For the signal to be transmitted, two EGFR molecules need to come together to form a homodimer. These then use the molecule of ATP to trans-phosphorylate each other on tyrosine residues, which generates phosphotyrosine residues, recruiting the phosphotyrosine-binding proteins to EGFR to assemble protein complexes that transduce signal cascades to the nucleus or activate other cellular biochemical processes. When erlotinib binds to EGFR, formation of phosphotyrosine residues in EGFR is not possible and the signal cascades are not initiated.
DC2101	Erlotinib free base Featured	Erlotinib (OSI-744; NSC 718781; R1415) is an EGFR inhibitor with IC50 of 2 nM, >1000-fold more sensitive for EGFR than human c-Src or v-Abl.
DC3139	Erlotinib hydrochloride Featured	Erlotinib HCl is an HER1/EGFR inhibitor with IC50 of 2 nM.
DCAPI1477	Ertapenem Featured	Ertapenem is a carbapenem antibiotic marketed by Merck as Invanz.
DCAPI1476	Ertapenem Sodium Featured	Ertapenem Sodium
DC8440	Erythromycin Cyclocarbonate Featured	Erythromycin Cyclocarbonate, derivative of Erythromycin, inhibits protein synthesis of bacteria by binding to the 50S ribosome.
DC7409	E-Mycin	Erythromycin, an oral macrolide antibiotic produced by Streptomyces erythreus, reversibly binds to the 50S ribosome of bacteria, and inhibits protein synthesis.
DC20244	ES9-17 Featured	ES9-17 is a novel CME inhibitor.
DC10211	Escin	Escin is a mixture of saponins with anti-inflammatory, vasoconstrictor and vasoprotective effects found in Aesculus hippocastanum(the horse chestnut).
DC4171	Escitalopram oxalate Featured	Escitalopram Oxalate is a selective serotonin (5-HT) reuptake inhibitor (SSRI) with Ki of 0.89 nM.
DC21000	ESI-05 Featured	ESI-05 is a potent EAPC2-specific antagonist that inhibits cAMP-mediated EPAC2 GEF activity with apparent IC50 of 0.43 uM.
DC8443	ESI-09 Featured	ESI-09 is a specific exchange protein directly activated by cAMP (EPAC) inhibitor with IC50 of 3.2 μM and 1.4 μM for EPAC1 and EPAC2, respectively, >100-fold selectivity over PKA.
DC9565	Eslicarbazepine (acetate)	Eslicarbazepine acetate (BIA 2-093) is an antiepileptic drug.
DC12325	Eslicarbazepine (BIA 2-194)	Eslicarbazepine is an oral anticonvulsant indicated for the adjunctive treatment of partial seizures.
DCAPI1423	Esomeprazole	Esomeprazole
DCAPI1487	Esomeprazole(magnesium)	Esomeprazole(magnesium)
DC10714	Esonarimod (KE-298) Featured	Esonarimod (KE-298) is a new antirheumatic drug.
DC23056	esperamicin A1 Featured	Esperamicin A1 is an enediyne antitumor antibiotics of bacterial origin.
DCAPI1200	Estradiol	Estradiol
DC9440	Estropipate Featured	Estropipate is a form of estrogen, used to treat symptoms of menopause, also used to prevent osteoporosis.
DC3162	Eszopiclone	Eszopiclone is a nonbenzodiazepine hypnotic which is slightly effective for insomnia.
DC7770	Etamicastat	Etamicastat is a novel dopamine β-hydroxylase inhibitor
DC8182	Bempedoic Acid(ETC-1002;ESP-55016) Featured	ETC-1002(ESP-55016) is a novel, first-in-class, orally available, once-daily LDL-C lowering small molecule; activator of hepatic AMP-activated protein kinase (AMPK); also has potent inhibitory activity against hepatic ATP-citrate lyase(IC50=29 uM).
DC8489	ETC-159 Featured	ETC-159 is a potent and specific inhibitor of Wnt secretion. ETC-159 inhibits _beta_-catenin reporter activity in a dose-dependent manner with an IC50 of 2.9 nM.
DC21003	ETC-206 Featured	ETC-206 (ETC-1907206) is a novel potent, selective MNK1/2 inhibitor with IC50 of 64/86 nM, inhibits eIF4E phosphorylation inhibition in HeLa cell line with IC50 of 321 nM.
DC8123	ETH 157（Sodium ionophore II） Featured	ETH 157（Sodium ionophore II）is a neutral ionophore for liquid-membrane electrodes of high selectivity for Na+.
DC9016	Etamsylate	Ethamsylate is a haemostatic drug, also inhibits biosynthesis and action of those prostaglandins.

Products

Customized Consultation X

Your information is safe with us. * Required Fields.